Annual CFF
$472.43 M
+$401.54 M+566.47%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual cash flow from financing activities is $472.43 million, with the most recent change of +$401.54 million (+566.47%) on March 31, 2024.
- During the last 3 years, IMVT annual CFF has risen by +$89.31 million (+23.31%).
- IMVT annual CFF is now at all-time high.
Performance
IMVT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.46 M
+$1.73 M+237.53%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly cash flow from financing activities is $2.46 million, with the most recent change of +$1.73 million (+237.53%) on December 31, 2024.
- Over the past year, IMVT quarterly CFF has dropped by -$467.38 million (-99.48%).
- IMVT quarterly CFF is now -99.48% below its all-time high of $469.84 million, reached on December 31, 2023.
Performance
IMVT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$5.42 M
-$467.38 M-98.85%
December 31, 2024
Summary
- As of February 12, 2025, IMVT TTM cash flow from financing activities is $5.42 million, with the most recent change of -$467.38 million (-98.85%) on December 31, 2024.
- Over the past year, IMVT TTM CFF has dropped by -$465.69 million (-98.85%).
- IMVT TTM CFF is now -98.85% below its all-time high of $472.81 million, reached on September 30, 2024.
Performance
IMVT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMVT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +566.5% | -99.5% | -98.8% |
| 3 y3 years | +23.3% | +100.0% | -97.3% |
| 5 y5 years | +221.4% | - | - |
IMVT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +566.5% | -99.5% | -100.0% | -98.8% | >+9999.0% |
| 5 y | 5-year | at high | +566.5% | -99.5% | -100.0% | -98.8% | >+9999.0% |
| alltime | all time | at high | +566.5% | -99.5% | +1494.5% | -98.8% | +3170.2% |
Immunovant Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $2.46 M(+237.5%) | $5.42 M(-98.9%) |
| Sep 2024 | - | $730.00 K(+6.4%) | $472.81 M(+0.1%) |
| Jun 2024 | - | $686.00 K(-55.6%) | $472.22 M(-0.0%) |
| Mar 2024 | $472.43 M(+566.5%) | $1.54 M(-99.7%) | $472.43 M(+0.3%) |
| Dec 2023 | - | $469.84 M(>+9900.0%) | $471.12 M(+555.2%) |
| Sep 2023 | - | $148.00 K(-83.4%) | $71.90 M(+0.2%) |
| Jun 2023 | - | $890.00 K(+282.0%) | $71.75 M(+1.2%) |
| Mar 2023 | $70.89 M(-64.6%) | $233.00 K(-99.7%) | $70.89 M(+0.3%) |
| Dec 2022 | - | $70.63 M(>+9900.0%) | $70.65 M(>+9900.0%) |
| Sep 2022 | - | $0.00(-100.0%) | $21.00 K(-100.0%) |
| Jun 2022 | - | $21.00 K(>+9900.0%) | $200.06 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | $200.13 M(-47.8%) | $0.00(0.0%) | $200.13 M(-0.4%) |
| Dec 2021 | - | $0.00(-100.0%) | $200.89 M(-0.2%) |
| Sep 2021 | - | $200.04 M(>+9900.0%) | $201.34 M(+6.2%) |
| Jun 2021 | - | $91.00 K(-88.1%) | $189.65 M(-50.5%) |
| Mar 2021 | $383.11 M(+160.7%) | $763.00 K(+71.1%) | $383.11 M(+0.2%) |
| Dec 2020 | - | $446.00 K(-99.8%) | $382.35 M(+0.1%) |
| Sep 2020 | - | $188.35 M(-2.7%) | $381.90 M(+97.3%) |
| Jun 2020 | - | $193.55 M(>+9900.0%) | $193.55 M(+65.7%) |
| Mar 2020 | $146.97 M | - | - |
| Sep 2019 | - | $0.00(-100.0%) | $116.82 M(0.0%) |
| Jun 2019 | - | $116.99 M(<-9900.0%) | $116.82 M(<-9900.0%) |
| Mar 2019 | - | -$176.70 K | -$176.70 K |
FAQ
- What is Immunovant annual cash flow from financing activities?
- What is the all time high annual CFF for Immunovant?
- What is Immunovant annual CFF year-on-year change?
- What is Immunovant quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Immunovant?
- What is Immunovant quarterly CFF year-on-year change?
- What is Immunovant TTM cash flow from financing activities?
- What is the all time high TTM CFF for Immunovant?
- What is Immunovant TTM CFF year-on-year change?
What is Immunovant annual cash flow from financing activities?
The current annual CFF of IMVT is $472.43 M
What is the all time high annual CFF for Immunovant?
Immunovant all-time high annual cash flow from financing activities is $472.43 M
What is Immunovant annual CFF year-on-year change?
Over the past year, IMVT annual cash flow from financing activities has changed by +$401.54 M (+566.47%)
What is Immunovant quarterly cash flow from financing activities?
The current quarterly CFF of IMVT is $2.46 M
What is the all time high quarterly CFF for Immunovant?
Immunovant all-time high quarterly cash flow from financing activities is $469.84 M
What is Immunovant quarterly CFF year-on-year change?
Over the past year, IMVT quarterly cash flow from financing activities has changed by -$467.38 M (-99.48%)
What is Immunovant TTM cash flow from financing activities?
The current TTM CFF of IMVT is $5.42 M
What is the all time high TTM CFF for Immunovant?
Immunovant all-time high TTM cash flow from financing activities is $472.81 M
What is Immunovant TTM CFF year-on-year change?
Over the past year, IMVT TTM cash flow from financing activities has changed by -$465.69 M (-98.85%)